B. Potter

发表

Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects.

Adolfo Saiardi, Stefano Iacobelli, A. M. Riley, 2005, Cancer research.

17β‐hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone‐dependent breast cancer

B. Potter, H. Tutill, B. Potter, 2008 .

STX140 and STX641 cause apoptosis via the intrinsic mitochondrial pathway and down-regulate survivin and XIAP expression in ovarian and prostate cancer cells.

B. Potter, A. Purohit, M. Reed, 2009, Anticancer research.

3-position modification of myo-inositol 1,4,5-trisphosphate: consequences for intracellular Ca2+ mobilisation and enzyme recognition.

B. Potter, S. Safrany, S. Nahorski, 1992, European journal of pharmacology.

Characterisation of stereospecific binding sites for inositol 1,4,5‐trisphosphate in airway smooth muscle

P. Barnes, R. Challiss, B. Potter, 1990, British journal of pharmacology.

Inositol trisphosphate analogues induce different oscillatory patterns in Xenopus oocytes.

M. Berridge, B. Potter, 1990, Cell regulation.

Docking studies of sulphamate inhibitors of estrone sulphatase in human carbonic anhydrase II.

Atul Purohit, B. Potter, A. Purohit, 2003, Bioorganic & medicinal chemistry letters.

STX140 Is Efficacious In vitro and In vivo in Taxane-Resistant Breast Carcinoma Cells

B. Potter, J. Day, A. Purohit, 2008, Clinical Cancer Research.

STX140 Is Efficacious In vitro and In vivo in Taxane-Resistant Breast Carcinoma Cells

B. Potter, J. Day, A. Purohit, 2008, Clinical Cancer Research.

Synthesis and characterization of an octanucleotide containing the EcoRI recognition sequence with a phosphorothioate group at the cleavage site.

A. Pingoud, B. Potter, F. Eckstein, 1984, Biochemistry.

Visualizing context-dependent calcium signaling in encephalitogenic T cells in vivo by two-photon microscopy

R. Hohlfeld, B. Potter, H. Wekerle, 2017, Proceedings of the National Academy of Sciences.

Inositol polyphosphate‐mediated iron transport in Pseudomonas aeruginosa

A. M. Riley, B. Potter, D. Poyner, 1999, Journal of applied microbiology.

[3H]-Methyllycaconitine: a high affinity radioligand that labels invertebrate nicotinic acetylcholine receptors.

S. Reynolds, B. Potter, A. Wolstenholme, 2001, Insect biochemistry and molecular biology.

Cellular Internalisation of an Inositol Phosphate Visualised by Using Fluorescent InsP5

A. M. Riley, B. Potter, S. Windhorst, 2013, Chembiochem : a European journal of chemical biology.

Injection of inositol trisphosphorothioate into Limulus ventral photoreceptors causes oscillations of free cytosolic calcium

R. Payne, B. Potter, L., 1991, The Journal of general physiology.

Adenophostin A Can Stimulate Ca2+ Influx without Depleting the Inositol 1,4,5-Trisphosphate-sensitive Ca2+ Stores in the Xenopus Oocyte*

B. Potter, K. Tanzawa, S. Delisle, 1997, The Journal of Biological Chemistry.

Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response

A. M. Riley, R. Xavier, S. Snyder, 2014, PLoS pathogens.

Synthesis from quebrachitol of 1L-chiro-inositol 2,3,5-trisphosphate, an inhibitor of the enzymes of 1D-myo-inositol 1,4,5-trisphosphate metabolism

B. Potter, Changsheng Liu, Stefan R. Nahorski, 1992 .

D-myo-Inositol 1,4,5-Trisphosphate Analogues Modified at the 3-Position Inhibit Phosphatidylinositol 3-Kinase (*)

J. Westwick, S. Ward, B. Potter, 1995, The Journal of Biological Chemistry.

Synthesis of (±)-3-O-alkylated Myo-inositol 1,4,5-trisphosphate analogues as potent receptor ligands and enzyme inhibitors

B. Potter, Changsheng Liu, 1994 .

Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.

B. Potter, S. Safrany, S. Nahorski, 1994, European journal of biochemistry.

Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase.

N. J. Noble, B. Potter, S. Safrany, 1994, Biochemistry.

The role of the 2- and 3-hydroxyl groups of 1D-myo-inositol 1,4,5-trisphosphate in the mobilisation of calcium from permeabilised human 1321N1 astrocytoma cells.

B. Potter, S. Nahorski, R. A. Wilcox, 1992, Carbohydrate research.

myo‐Inositol 1,4,5‐trisphosphorothioate is a potent competitive inhibitor of human erythrocyte 5‐phosphatase

B. Potter, S. Nahorski, A. Cooke, 1989, FEBS letters.

Molecular recognition of inositol polyphosphates by intracellular receptors and metabolic enzymes.

B. Potter, S. Nahorski, S. R. Nahorski, 1989, Trends in pharmacological sciences.

Ca2+‐mobilising properties of synthetic fluoro‐analogues of myo‐inositol 1,4,5‐trisphosphate and their interaction with myo‐inositol 1,4,5‐trisphosphate 3‐kinase and 5‐phosphatase

R. Wojcikiewicz, B. Potter, S. Safrany, 1990, FEBS letters.

Interaction of synthetic D‐6‐deoxy‐myo‐inositol 1,4,5‐trisphosphate with the Ca2+‐releasing D‐myo‐inositol 1,4,5‐trisphosphate receptor, and the metabolic enzymes 5‐phosphatase and 3‐kinase

R. Wojcikiewicz, B. Potter, S. Safrany, 1991, FEBS letters.

Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.

R. Wojcikiewicz, B. Potter, S. Safrany, 1991, Molecular pharmacology.

myo-Inositol phosphorothioates, phosphatase-resistant analogues of myo-inositol phosphates. Synthesis of DL-myo-inositol 1,4-bisphosphate and DL-myo-inositol 1,4-bisphosphorothioate.

Michael R Hamblin, M. Hamblin, B. Potter, 1987, The Biochemical journal.

DL-myo-inositol 1,4,5-trisphosphorothioate mobilizes intracellular calcium in Swiss 3T3 cells and Xenopus oocytes.

M. Berridge, C. Taylor, B. Potter, 1988, Biochemical and biophysical research communications.

Stereospecific mobilization of intracellular Ca2+ by inositol 1,4,5-triphosphate. Comparison with inositol 1,4,5-trisphosphorothioate and inositol 1,3,4-trisphosphate.

B. Potter, S. Nahorski, R. Gigg, 1988, The Biochemical journal.

Myo-inositol(1,4,5)trisphosphorothioate binds to specific [3H]inositol(1,4,5)trisphosphate sites in rat cerebellum and is resistant to 5-phosphatase.

B. Potter, S. Nahorski, A. L. Willcocks, 1988, European journal of pharmacology.

Inositol 1,4,5-trisphosphorothioate, a stable analogue of inositol trisphosphate which mobilizes intracellular calcium.

M. Berridge, C. Taylor, B. Potter, 1989, The Biochemical journal.

Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.

B. Potter, S. Safrany, S. Nahorski, 1993, Molecular pharmacology.

The metabolism of D-myo-inositol 1,4,5-trisphosphate and D-myo-inositol 1,3,4,5-tetrakisphosphate by porcine skeletal muscle.

P. Foster, B. Potter, S. Hogan, 1994, European journal of biochemistry.

Synthesis of selective non-Ca(2+)-mobilizing inhibitors of D-myo-inositol 1,4,5-trisphosphate 5-phosphatase.

B. Potter, C. Liu, D. Lampe, 1994, Journal of medicinal chemistry.

Synthesis of 3-Position-Modified Analogues of myo-Inositol 1,4,5-Trisphosphate, Tools for Investigation of the Polyphosphoinositide Pathway of Cellular Signaling.

B. Potter, C. Liu, 1997, The Journal of organic chemistry.

Inositol 1,3,4-Trisphosphate Acts in Vivo as a Specific Regulator of Cellular Signaling by Inositol 3,4,5,6-Tetrakisphosphate*

A. M. Riley, C. Schultz, M. Yoshida, 1999, The Journal of Biological Chemistry.

Selective recognition of inositol phosphates by subtypes of the inositol trisphosphate receptor.

A. M. Riley, C. Taylor, B. Potter, 2001, The Biochemical journal.

Synthesis of potent Ins(1,4,5)P3 5-phosphatase inhibitors by modification of myo-inositol 1,3,4,6-tetrakisphosphate.

B. Potter, S. J. Mills, 2003, Bioorganic & medicinal chemistry.

E. coli Ada regulatory protein repairs the Sp diastereoisomer of alkylated DNA

Michael R Hamblin, M. Hamblin, B. Potter, 1985, FEBS letters.

Discovery of Adamantyl Heterocyclic Ketones as Potent 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors

Mark P Thomas, B. Potter, M. Culler, 2011, ChemMedChem.

Novel inhibitors of 17beta-hydroxysteroid dehydrogenase type 1: templates for design.

H. Tutill, B. Potter, J. Day, 2008, Bioorganic & medicinal chemistry.

E-ring modified steroids as novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

H. Tutill, G. Packham, B. Potter, 2005, Journal of medicinal chemistry.

Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

H. Tutill, B. Potter, J. Day, 2006, Journal of medicinal chemistry.

Novel, potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1

H. Tutill, B. Potter, M. Reed, 2006, Molecular and Cellular Endocrinology.

Novel and potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors.

H. Tutill, B. Potter, A. Purohit, 2005, Journal of medicinal chemistry.

A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents.

B. Potter, A. Purohit, M. Reed, 2005, Journal of medicinal chemistry.

scyllo‐Inositol Pentakisphosphate as an Analogue of myo‐Inositol 1,3,4,5,6‐Pentakisphosphate: Chemical Synthesis, Physicochemistry and Biological Applications

A. M. Riley, M. Borkovec, B. Potter, 2006, Chembiochem : a European journal of chemical biology.

Regulation of Casein Kinase-2 (CK2) Activity by Inositol Phosphates*

A. M. Riley, A. Tobin, B. Potter, 2004, Journal of Biological Chemistry.

A structural exposé of noncanonical molecular reactivity within the protein tyrosine phosphatase WPD loop

A. M. Riley, L. Perera, Huanchen Wang, 2022, Nature Communications.

Rapid functional assays of recombinant IP3 receptors.

Colin W. Taylor, A. Laude, S. Lummis, 2005, Cell calcium.

Inframolecular acid-base and coordination properties towards Na(+) and Mg(2+) of myo-inositol 1,3,4,5,6-pentakisphosphate: a structural approach to biologically relevant species.

A. M. Riley, H. Y. Godage, B. Potter, 2013, Dalton transactions.

Novel 18β-glycyrrhetinic acid analogues as potent and selective inhibitors of 11β-hydroxysteroid dehydrogenases

B. Potter, A. Purohit, M. Reed, 2004 .

A novel 18β-glycyrrhetinic acid analogue as a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase 2

B. Potter, A. Purohit, M. Reed, 2004 .

Dimers of D-myo-inositol 1,4,5-trisphosphate: design, synthesis, and interaction with Ins(1,4,5)P3 receptors.

A. M. Riley, Colin W. Taylor, A. Laude, 2004, Bioconjugate chemistry.

Synthetic partial agonists reveal key steps in IP3 receptor activation

A. M. Riley, Colin W. Taylor, B. Potter, 2009, Nature chemical biology.

Subtype-selective regulation of IP3 receptors by thimerosal via cysteine residues within the IP3-binding core and suppressor domain

A. M. Riley, Colin W. Taylor, B. Potter, 2013, The Biochemical journal.

Multiple substrate recognition by yeast diadenosine and diphosphoinositol polyphosphate phosphohydrolase through phosphate clamping

A. M. Riley, B. González, B. Potter, 2021, Science Advances.

Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2)

B. Potter, J. Chernoff, K. Barald, 2019, BMC Pharmacology and Toxicology.

Allosteric Site on SHIP2 Identified Through Fluorescent Ligand Screening and Crystallography: A Potential New Target for Intervention

A. M. Riley, C. Brearley, A. Hemmings, 2021, Journal of medicinal chemistry.

An ATP-responsive metabolic cassette comprised of inositol tris/tetrakisphosphate kinase 1 (ITPK1) and inositol pentakisphosphate 2-kinase (IPK1) buffers diphosphosphoinositol phosphate levels

A. M. Riley, C. Brearley, A. Hemmings, 2020, The Biochemical journal.

A Fluorescent Probe Identifies Active Site Ligands of Inositol Pentakisphosphate 2-Kinase.

A. M. Riley, C. Brearley, A. Hemmings, 2018, Journal of medicinal chemistry.

BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure

H. Tutill, B. Potter, J. Day, 2009, British Journal of Cancer.

Inositol trisphosphate analogues selective for types I and II inositol trisphosphate receptors exert differential effects on vasopressin-stimulated Ca2+ inflow and Ca2+ release from intracellular stores in rat hepatocytes.

A. M. Riley, B. Potter, G. Barritt, 2004, The Biochemical journal.

Identification of Mammalian Vps24p as an Effector of Phosphatidylinositol 3,5-Bisphosphate-dependent Endosome Compartmentalization*

A. M. Riley, Barbara J. Reaves, P. Whitley, 2003, Journal of Biological Chemistry.

Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors

Mark P Thomas, B. Potter, E. Hamel, 2011, ACS medicinal chemistry letters.

Ca2+ release by inositol-trisphosphorothioate in isolated triads of rabbit skeletal muscle.

C. Valdivia, B. Potter, R. Coronado, 1990, Biophysical journal.

Regioisomeric Family of Novel Fluorescent Substrates for SHIP2

A. M. Riley, C. Brearley, B. Potter, 2019, ACS medicinal chemistry letters.

2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique

B. Potter, A. Purohit, M. Reed, 2008, Breast Cancer Research and Treatment.

Rapid and efficient routes to phosphatidylinositol 3,4,5-trisphosphates via myo-inositol orthobenzoate

A. M. Riley, B. Potter, K. M. Sureshan, 2007 .

STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model.

H. Tutill, B. Potter, J. Day, 2013, Endocrine-related cancer.

myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3, 6-trisphosphorothioate: partial agonists with very low intrinsic activity at the platelet myo-inositol 1,4,5-trisphosphate receptor.

A. M. Riley, J. Westwick, B. Potter, 2000, Molecular pharmacology.

Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells.

R. Challiss, B. Potter, S. Nahorski, 1993, Molecular pharmacology.

Regulation of Ins(3,4,5,6)P4 Signaling by a Reversible Kinase/Phosphatase

A. M. Riley, B. Potter, Yong‐Uk Kwon, 2002, Current Biology.

Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates

B. Potter, Mark P Thomas, B. Potter, 2011, ChemMedChem.

Oxygen chiral phosphate in uridylyl(3'.fwdarw.5')adenosine by oxidation of a phosphite intermediate: synthesis and absolute configuration

B. Potter, F. Seela, J. Ott, 1983 .

Optimisation of Tetrahydroisoquinoline‐Based Chimeric Microtubule Disruptors

B. Potter, E. Hamel, M. Leese, 2014, ChemMedChem.

Inhibition of inositol 1,4,5‐trisphosphate metabolism in permeabilised SH‐SY5Y human neuroblastoma cells by a phosphorothioate‐containing analogue of inositol 1,4,5‐trisphosphate

R. Wojcikiewicz, B. Potter, S. Nahorski, 1990 .

NovelInositolPhospholipidHeadgroupSurrogate CrystallizedinthePleckstrinHomologyDomainof ProteinKinaseB

D. Komander, B. Potter, S. Safrany, 2007 .

Synthesis and evaluation of thiadiazole derivatives as inhibitors of 11β-hydroxysteroid dehydrogenase type 1

Mark P Thomas, B. Potter, M. Culler, 2012 .

Inhibition of human and rat 11β-hydroxysteroid dehydrogenase type 1 by 18β-glycyrrhetinic acid derivatives

B. Potter, A. Purohit, M. Reed, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

A comparison of two orally bioavailable anti-cancer agents, IRC-110160 and STX140.

B. Potter, A. Purohit, M. Reed, 2008, Anticancer research.

Chemistry of Inositol Lipid Mediated Cellular Signaling

B. Potter, D. Lampe, 1995 .

Synthesis of D- and L-myo-inositol 1,2,4,6-tetrakisphosphate, regioisomers of myo-inositol 1,3,4,5 tetrakisphosphate: activity against Ins(1,4,5)P3 binding proteins.

B. Potter, C. Erneux, S. J. Mills, 2003, Organic & biomolecular chemistry.

An autoradiographic study of the distribution of binding sites for the novel α7‐selective nicotinic radioligand [3H]‐methyllycaconitine in the mouse brain

A. C. Collins, A. Collins, B. Potter, 1999, The European journal of neuroscience.

Regioselective Opening of myo-Inositol Orthoesters: Mechanism and Synthetic Utility

A. M. Riley, Mark P Thomas, H. Y. Godage, 2013, The Journal of organic chemistry.

l-α-Phosphatidyl-d-myo-inositol 3,5-bisphosphate: total synthesis of a new inositol phospholipid via myo-inositol orthoacetate

A. M. Riley, B. Potter, 1998 .

Association of the inositol (1,4,5)-trisphosphate receptor ligand binding site with phosphatidylinositol (4,5)-bisphosphate and adenophostin A.

I. Bezprozvanny, B. Potter, J. Falck, 2000, Molecular cell biology research communications : MCBRC.

Stereochemical course of DNA hydrolysis by nuclease S1.

B. Potter, F. Eckstein, P. Romaniuk, 1983, The Journal of biological chemistry.

Synthesis of 4,8-anhydro-D-glycero-D-ido-nonanitol 1,6,7-trisphosphate as a novel IP3 receptor ligand using a stereoselective radical cyclization reaction based on a conformational restriction strategy

Colin W. Taylor, S. Shuto, A. Matsuda, 2005 .

Synthesis, Antitubulin, and Antiproliferative SAR of C3/C1‐Substituted Tetrahydroisoquinolines

B. Potter, B. Potter, A. Purohit, 2014, ChemMedChem.

Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling.

B. Potter, A. Purohit, M. Reed, 2008, Organic & biomolecular chemistry.

Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-O-sulfamates

B. Potter, A. Purohit, M. Reed, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

A letrozole-based dual aromatase–sulphatase inhibitor with in vivo activity

B. Potter, B. Potter, A. Purohit, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

Heteroatom-substituted analogues of the active-site directed inhibitor estra-1,3,5(10)-trien-17-one-3-sulphamate inhibit estrone sulphatase by a different mechanism

B. Potter, A. Purohit, M. Reed, 1996, The Journal of Steroid Biochemistry and Molecular Biology.

Studies on the substituted 3-aminopropan-1-ol motif of lycoctonine class norditerpenoid alkaloids: A novel route to 3-hydroxymethylcyclohex-2-enone

B. Potter, I. S. Blagbrough, N. F. Thomas, 1998 .

Synthesis of C5-substituted AE-bicyclic analogues of lycoctonine, inuline and methyllycaconitine

B. Potter, I. S. Blagbrough, W. Trigg, 1998 .

Fibrinogen - a possible extracellular target for inositol phosphates.

A. M. Riley, B. Potter, S. Safrany, 2012, Messenger.

Synthesis of L-scyllo-inositol 1,2,4-trisphosphate, scyllo-inositol 1,2,4,5-tetrakisphosphate and phosphorothioate and DL-2-deoxy-2-fluoro-myo-inositol 1,4,5-trisphosphate: optical resolution of DL-1-O-allyl-3,6-di-O-benzyl-4,5-O-isopropylidene-scyllo-inositol

B. Potter, M. Mahon, Changsheng Liu, 1996 .

Myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3,4-trisphosphorothioate: New synthetic Ca2+-mobilising partial agonists at the inositol 1,4,5-trisphosphate receptor

A. M. Riley, J. Westwick, B. Potter, 1995 .

(2-Hydroxyethyl)-α-D-glucopyranoside-2′,3,4-trisphosphate: synthesis of a second messenger mimic related to adenophostin A

B. Potter, D. J. Jenkins, 1995 .

Synthesis of myo-inositol 1,4,5-trisphosphate 3-phosphorothioate as an inhibitor of myo-inositol 1,3,4,5-tetrakisphosphate 3-phosphatase

B. Potter, Changsheng Liu, 1994 .

Myo-inositol 1,4,6-trisphosphate: A new synthetic Ca2+-mobilising inositol phosphate

J. Westwick, B. Potter, S. J. Mills, 1993 .

Synthesis of myo-inositol 1,2,4,5-tetrakisphosphate, a Ca2+-mobilising tetrakisphosphate with a potency similar to myo-inositol 1,4,5-trisphosphate

B. Potter, S. Safrany, S. Nahorski, 1993 .

Synthesis of 2-fluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate and scyllo-inositol 1,2,4-trisphosphate, novel analogues of the second messenger myo-inositol 1,4,5-trisphosphate

B. Potter, D. Lampe, 1993 .

Synthetic Analogues of the Second Messenger D-MYO Inositol 1,4,5 Trisphosphate as Receptor Agonists and Inhibitors of the Enzymes of the Polyphosphoinositide Pathway of Signal Transduction

B. Potter, 1993 .

Synthesis of racemic myo-inositol 1,4,5-trisphosphate 3-O-methylenecarboxylate, a Ca2+-mobilising myo-lnositol 1,3,4,5-tetrakisphosphate analogue

B. Potter, N. F. Thomas, Changsheng Liu, 1993 .

Synthesis of (±)-myo-inositol 1,4,5-trisphosphate and the novel analogue (±)-myo-inositol 1,4-bisphosphate 5-phosphorothioate

N. J. Noble, B. Potter, A. Cooke, 1992 .

Total synthesis of the second messenger analogue D-myo-inositol 1-phosphorothioate 4,5-bisphosphate: optical resolution of DL-1-O-allyl-2,3,6-tri-O-benzyl-myo-inositol and fluorescent labelling of myo-inositol 1,4,5-trisphosphate

B. Potter, S. J. Mills, D. Lampe, 1992 .

Total synthesis of fluorinated analogues of inositol and inositol 1,4,5-trisphosphate

B. Potter, D. Sawyer, 1992 .

Total synthesis of myo-inositol-1-phosphate-4,5-pyrophosphate, a novel second messenger analogue, via myo-inositol-1-phosphate-4,5-bisphosphorothioate

N. J. Noble, B. Potter, D. Dubreuil, 1992 .

Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor.

B. Potter, S. Safrany, S. Nahorski, 1992, Chirality.

Total synthesis of L-2,2-difluoro-2-deoxy-MYO-inositol 1,4,5-trisphosphate, a potent inhibitor of the enzymes of d-MYO-inositol 1,4,5-trisphosphate metabolism

B. Potter, D. Sawyer, 1991 .

The effect of myo-inositol 1,4,5-trisphosphorothioate on Cl- current pattern and intracellular Ca2+ in the Xenopus laevis oocyte.

B. Potter, R. Nuccitelli, J. Ferguson, 1990, Biochemical and biophysical research communications.

Phosphorothioate analogues of inositol phosphates

B. Potter, S. Nahorski, A. Cooke, 1990 .

Synthesis of myo-inositol 1-phosphorothioate 4,5-bisphosphate: Preparation of a fluorescently labelled myo-inositol 1,4,5-trisphosphate analogue

B. Potter, D. Lampe, 1990 .

Evidence against a step-wise mechanism for the fumarase-catalysed dehydration of (2S)-malate.

B. Potter, G. Lowe, V. Jones, 1980, European journal of biochemistry.

Stereospecific recognition sites for [3H]inositol(1,4,5)-triphosphate in particulate preparations of rat cerebellum.

B. Potter, S. Nahorski, A. L. Willcocks, 1987, Biochemical and biophysical research communications.

Discovery of novel inhibitors of human 11β-hydroxysteroid dehydrogenase type 1

B. Potter, M. Culler, N. Vicker, 2009, Molecular and Cellular Endocrinology.

Novel non-steroidal inhibitors of human 11β-hydroxysteroid dehydrogenase type 1

B. Potter, A. Purohit, M. Reed, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

Benzothiazole derivatives as novel inhibitors of human 11β-hydroxysteroid dehydrogenase type 1

B. Potter, A. Purohit, M. Reed, 2006, Molecular and Cellular Endocrinology.

Isotopic Enrichment by Asymmetric Deuteriation. An Investigation of the Synthesis of Deuteriated (S)-(−)-Methylsuccinic Acids from Itaconic Acid

B. Potter, I. S. Blagbrough, D. Hardick, 1996 .

Synthesis and Ca2+-mobilizing activity of purine-modified mimics of adenophostin A: a model for the adenophostin-Ins(1,4,5)P3 receptor interaction.

A. M. Riley, Colin W. Taylor, A. Laude, 2003, Journal of medicinal chemistry.

A Synthetic Polyphosphoinositide Headgroup Surrogate in Complex with SHIP2 Provides a Rationale for Drug Discovery

A. M. Riley, P. Nordlund, Mark P Thomas, 2012, ACS chemical biology.

Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol

B. Potter, D. Jewett, K. Barald, 2015, British Journal of Cancer.

Calcium release activity and metabolism of inositol 1,4,5-trisphosphate in T cells. Modulation by novel inositol 1,4,5-trisphosphate 5-phosphatase inhibitors.

J. Westwick, S. Ward, B. Potter, 1994, European journal of biochemistry.

2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity.

C. Supuran, B. Potter, A. Purohit, 2006, Journal of medicinal chemistry.

Synthesis of novel unsaturated AE-bicyclic analogues of lycoctonine, inuline and methyllycaconitine: With olefinic J = 13.5 Hz, but still cis

B. Potter, I. S. Blagbrough, W. Trigg, 1998 .

Preliminary Synthetic Studies of Methyllycaconitine, a Potent Nicotinic Acetylcholine Receptor Antagonist: Rapid Syntheses of AE‐Bicyclic Analogues

B. Potter, I. S. Blagbrough, T. Lewis, 1996, The Journal of pharmacy and pharmacology.

Rapid and efficient isolation of the nicotinic receptor antagonist methyllycaconitine from delphinium:assignment of the methylsuccinimide absolute stereochemistry as S

B. Potter, I. S. Blagbrough, S. Wonnacott, 1994 .

Rapid and efficient entry to substituted 2-succinimidobenzoate-3-azabicyclo[3.3.1]nonanes: AE-bicyclic analogues of methyllycaconitine

B. Potter, I. S. Blagbrough, T. Lewis, 1994 .

Design and synthesis of 4″,6″-unsaturated cyclic ADP-carbocyclic ribose as a Ca 2+ -mobilizing agent

S. Shuto, A. Matsuda, B. Potter, 2008 .

Inositol pentakisphosphate promotes apoptosis through the PI 3-K/Akt pathway

A. M. Riley, P. Pandolfi, S. Iacobelli, 2004, Oncogene.

Conversion of the sodium channel activator aconitine into a potent α7‐selective nicotinic ligand

B. Potter, I. S. Blagbrough, S. Wonnacott, 1995, FEBS letters.

Rapid and Efficient Microwave‐Assisted Friedländer Quinoline Synthesis

B. Potter, N. Vicker, M. Mahon, 2020, ChemistryOpen.

Synthesis of adenophostin A

Colin W. Taylor, B. Potter, V. Correa, 2000 .

Synthesis of glucopyranoside-based ligands for D-myo-inositol 1,4,5-trisphosphate receptors.

A. M. Riley, B. Potter, D. J. Jenkins, 2002, Carbohydrate research.

Synthesis of adenophostin A and congeners modified at glucose

A. M. Riley, B. Potter, D. J. Jenkins, 2000 .

Bicyclic analogues of inositol 1,4,5-trisphosphate based upon adenophostin A

A. M. Riley, B. Potter, 1999 .

C-glycoside based mimics of D-myo-inositol 1,4,5-trisphosphate.

A. M. Riley, C. Taylor, B. Potter, 2000, Carbohydrate research.

α-Oxyiminophosphonates: chemical and physical properties. Reactions, theoretical calculations, and X-ray crystal structures of (E) and (Z)-dimethyl α-hydroxyiminobenzylphosphonates

A. Goldblum, B. Potter, D. Gibson, 1988 .

Rapid microwave-assisted reductive amination of ketones with anilines

B. Potter, N. Vicker, H. V. Bailey, 2006 .

A synthetic cyclitol-nucleoside conjugate polyphosphate is a highly potent second messenger mimic

Colin W. Taylor, B. Potter, Ana M. Rossi, 2019, Chemical science.

Total synthesis of nucleobase-modified adenophostin A mimics.

S. Shuto, B. Potter, G. Horne, 2001, Chemistry.

Total synthesis, from D-xylose, of chiral, ring-contracted 1D-myo-inositol 1,4,5-trisphosphate and 1,3,4,5-tetrakisphosphate analogues with C-2 excised

B. Potter, D. J. Jenkins, 1998 .

A disaccharide polyphosphate mimic of 1D-myo-inositol 1,4,5-trisphosphate

B. Potter, D. J. Jenkins, R. D. Marwood, 1997 .

Synthesis of D-2-deoxy-myo-inositol 1,3,4,5-tetrakisphosphate from D-glucose

B. Potter, D. Dubreuil, D. J. Jenkins, 1996 .

A Ca(2+)-mobilising carbohydrate-based polyphosphate: synthesis of 2-hydroxyethyl alpha-D-glucopyranoside 2',3,4-trisphosphate.

B. Potter, D. J. Jenkins, 1996, Carbohydrate research.

Chiral Cyclopentane-Based Mimics of D-myo-Inositol 1,4,5-Trisphosphate from D-Glucose.

A. M. Riley, B. Potter, D. J. Jenkins, 1996, The Journal of organic chemistry.

A Tandem Horner-Emmons Olefination-Conjugate Addition Approach to the Synthesis of 1,5-Disubstituted-6-azabicyclo[3.2.1]octanes Based on the AE Ring Structure of the Norditerpenoid Alkaloid Methyllycaconitine.

B. Potter, N. F. Thomas, David J. Callis, 1996, The Journal of organic chemistry.

Multivalent benzene polyphosphate derivatives are non-Ca2+-mobilizing Ins(1,4,5)P3 receptor antagonists.

J. Parys, B. Potter, C. Erneux, 2012, Messenger.

Inositol Adenophostin: Convergent Synthesis of a Potent Agonist of d-myo-Inositol 1,4,5-Trisphosphate Receptors

Colin W. Taylor, B. Potter, Ana M. Rossi, 2020, ACS omega.

Determination of the absolute configuration of aromatase and dual aromatase-sulfatase inhibitors by vibrational and electronic circular dichroism spectra analysis.

B. Potter, G. Longhi, S. Abbate, 2009, Chirality.

Aplysia californica mediated cyclisation of novel 3'-modified NAD+ analogues: a role for hydrogen bonding in the recognition of cyclic adenosine 5'-diphosphate ribose.

A. Galione, B. Potter, M. Migaud, 2004, Bioorganic & medicinal chemistry.

Stereochemical evidence for a phosphorylpyridinium intermediate in the iodine-mediated desulphurisation of a phosphorothioate diester

B. Potter, J. H. Cummins, 1985 .

Synthesis and configurational analysis of a dinucleoside phosphate isotopically chiral at phosphorus. Stereochemical course of Penicillium citrum nuclease P1 reaction.

B. Potter, F. Eckstein, B. Connolly, 1983, Biochemistry.

Simple synthesis of 32P-labelled inositol hexakisphosphates for study of phosphate transformations

A. M. Riley, C. Brearley, H. Y. Godage, 2017, Plant and Soil.

Effect of inositol trisphosphate and calcium on oscillating elevations of intracellular calcium in Xenopus oocytes.

K. Krause, M. Welsh, B. Potter, 1990, The Journal of biological chemistry.

The size of inositol 1,4,5-trisphosphate-sensitive Ca2+ stores depends on inositol 1,4,5-trisphosphate concentration.

C. Taylor, B. Potter, 1990, The Biochemical journal.

Pulsatile intracellular calcium release does not depend on fluctuations in inositol trisphosphate concentration

Ole H. Petersen, O. Petersen, B. Potter, 1989, Nature.

Synthetic Analogs of Intracellular Messengers

B. Potter, 1992 .

Stereoselectivity of Ins(1,3,4,5)P4 recognition sites: implications for the mechanism of the Ins(1,3,4,5)P4-induced Ca2+ mobilization.

A. Vasella, R. Challiss, B. Potter, 1993, The Biochemical journal.

The effect of 17O and the magnitude of the 18O-isotope shift in 31P nuclear magnetic resonance spectroscopy

B. Sproat, B. Potter, W. Hull, 1979 .

3‐Hydroxybenzene 1,2,4‐Trisphosphate, a Novel Second Messenger Mimic and unusual Substrate for Type‐I myo‐Inositol 1,4,5‐Trisphosphate 5‐Phosphatase: Synthesis and Physicochemistry

B. Potter, F. Vandeput, C. Erneux, 2006, Chembiochem : a European journal of chemical biology.

Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors

B. Potter, A. Wolstenholme, I. S. Blagbrough, 1999, Neuropharmacology.

Cover Picture: Tetrahydroisoquinolinone‐Based Steroidomimetic and Chimeric Microtubule Disruptors (ChemMedChem 1/2014)

B. Potter, E. Hamel, M. Leese, 2014 .

Structure–Activity Relationship for the First-in-Class Clinical Steroid Sulfatase Inhibitor Irosustat (STX64, BN83495)

B. Potter, Mark P Thomas, B. Potter, 2011, ChemMedChem.

A conformationally restricted cyclic phosphate analogue of inositol trisphosphate: synthesis and physicochemical properties

A. M. Riley, G. Schlewer, B. Potter, 1998 .

Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase.

B. Potter, A. Purohit, M. Reed, 2004, Bioorganic & medicinal chemistry.

On the mechanism of action of bovine intestinal mucosa 5'-nucleotide phosphodiesterase. Stereochemical evidence for a nucleotidyl-enzyme intermediate.

B. Potter, J. H. Cummins, 1987, European journal of biochemistry.

Cytosolic Ca2+ oscillations in REF52 fibroblasts: Ca(2+)-stimulated IP3 production or voltage-dependent Ca2+ channels as key positive feedback elements.

R. Tsien, J. Kao, S. Adams, 1991, Cell calcium.

Simplification of adenophostin A defines a minimal structure for potent glucopyranoside-based mimics of D-myo-inositol 1,4,5-trisphosphate.

A. M. Riley, C. Taylor, B. Potter, 1999, Bioorganic & medicinal chemistry letters.

Synthesis of an α-phosphono-α,α-difluoroacetamide analogue of the diphosphoinositol pentakisphosphate 5-InsP7

A. M. Riley, Huanchen Wang, B. Potter, 2019, MedChemComm.

d-chiro-Inositol Ribophostin: A Highly Potent Agonist of d-myo-Inositol 1,4,5-Trisphosphate Receptors: Synthesis and Biological Activities

B. Potter, Ana M. Rossi, D. Bakowski, 2020, Journal of medicinal chemistry.

Synthesis of the enantiomers of myo-inositol 1,2,4,5-tetrakisphosphate, a regioisomer of myo-inositol 1,3,4,5-tetrakisphosphate

B. Potter, S. J. Mills, 1997 .

Convergent synthesis of adenophostin A analogues via a base replacement strategy

S. Shuto, B. Potter, D. J. Jenkins, 2000 .

On the selectivity of stannylene-mediated alkylation and esterification of methyl 4,6-O-benzylidene α-d-glucopyranoside

B. Potter, D. J. Jenkins, 1994 .

Regioselective hydrolysis of myo-inositol 1,3,5-orthobenzoate via a 1,2-bridged 2'-phenyl-1',3'-dioxolan-2'-ylium ion provides a rapid route to the anticancer agent Ins(1,3,4,5,6)P5.

A. M. Riley, H. Y. Godage, B. Potter, 2006, Chemical communications.

6-Deoxy-6-hydroxymethyl scyllo-inositol 1,2,4-trisphosphate: A potent agonist at the inositol 1,4,5-trisphosphate receptor

A. M. Riley, J. Westwick, B. Potter, 1996 .

Contribution of Phosphates and Adenine to the Potency of Adenophostins at the IP3 Receptor: Synthesis of All Possible Bisphosphates of Adenophostin A

A. M. Riley, Mark P Thomas, B. Potter, 2012, Journal of medicinal chemistry.

Guanophostin A: Synthesis and evaluation of a high affinity agonist of the D-myo-inositol 1,4,5-trisphosphate receptor.

B. Potter, S. Tovey, K. M. Sureshan, 2006, Chemical communications.

Both d- and l-Glucose Polyphosphates Mimic d-myo-Inositol 1,4,5-Trisphosphate: New Synthetic Agonists and Partial Agonists at the Ins(1,4,5)P3 Receptor

A. M. Riley, C. Brearley, B. Potter, 2020, Journal of medicinal chemistry.

A synthetic diphosphoinositol phosphate analogue of inositol trisphosphate

A. M. Riley, T. Helleday, B. Potter, 2018, MedChemComm.

Designer small molecules to target calcium signalling.

A. M. Riley, B. Potter, S. J. Mills, 2015, Biochemical Society transactions.

Stimulation of Inositol 1,4,5-Trisphosphate (IP3) Receptor Subtypes by Adenophostin A and Its Analogues

A. M. Riley, B. Potter, H. Saleem, 2013, PloS one.

Selective determinants of inositol 1,4,5-trisphosphate and adenophostin A interactions with type 1 inositol 1,4,5-trisphosphate receptors

A. M. Riley, B. Potter, Ana M. Rossi, 2010, British journal of pharmacology.

Adenophostins: High-Affinity Agonists of IP(3) Receptors.

A. M. Riley, B. Potter, Ana M. Rossi, 2010, Current topics in membranes.

Activation of IP3 receptors by synthetic bisphosphate ligands

A. M. Riley, B. Potter, S. G. Dedos, 2009, Chemical communications.

Design and synthesis of 5'-deoxy-5'-phenyladenophostin A, a highly potent IP3 receptor ligand.

S. Shuto, A. Matsuda, Y. Kondo, 2006, Organic letters.

Interaction of the Catalytic Domain of Inositol 1,4,5‐Trisphosphate 3‐Kinase A with Inositol Phosphate Analogues

A. M. Riley, B. Potter, C. Erneux, 2005, Chembiochem : a European journal of chemical biology.

Adenophostin A and analogues modified at the adenine moiety: synthesis, conformational analysis and biological activity.

B. Potter, S. G. Dedos, S. Tovey, 2005, Organic & biomolecular chemistry.

Determinants of adenophostin A binding to inositol trisphosphate receptors.

A. M. Riley, S. Morris, B. Potter, 2002, The Biochemical journal.

Structural determinants of adenophostin A activity at inositol trisphosphate receptors.

A. M. Riley, S. Shuto, C. Taylor, 2001, Molecular pharmacology.

Rapid activation and partial inactivation of inositol trisphosphate receptors by adenophostin A.

C. Adkins, C. Taylor, B. Potter, 2000, The Biochemical journal.

Inframolecular studies of the protonation of adenophostin A: comparison with 1-D-myo-inositol 1,4,5-trisphosphate.

B. Potter, B. Spiess, M. Felemez, 1999, Biochemical and biophysical research communications.

Acyclophostin: a ribose-modified analog of adenophostin A with high affinity for inositol 1,4,5-trisphosphate receptors and pH-dependent efficacy.

A. M. Riley, G. A. van der Marel, C. Taylor, 1999, Molecular pharmacology.

Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors.

A. M. Riley, J. Westwick, B. Potter, 1997, Molecular pharmacology.

ICRAC, in weak intracellular Ca2+ buffer

A. M. Riley, B. Potter, A. Parekh, 2022 .

Cleavage of phosphorothioate-substituted DNA by restriction endonucleases.

B. Potter, F. Eckstein, 1984, The Journal of biological chemistry.

2-Position base-modified analogues of adenophostin A as high-affinity agonists of the D-myo-inositol trisphosphate receptor: in vitro evaluation and molecular modeling.

B. Potter, S. Tovey, K. M. Sureshan, 2008, The Journal of organic chemistry.

Synthesis of adenophostin A analogues conjugating an aromatic group at the 5'-position as potent IP3 receptor ligands.

S. Shuto, A. Matsuda, Y. Kondo, 2006, Journal of medicinal chemistry.

Binding of Inositol 1,4,5-trisphosphate (IP3) and Adenophostin A to the N-Terminal region of the IP3 Receptor: Thermodynamic Analysis Using Fluorescence Polarization with a Novel IP3 Receptor Ligand

A. M. Riley, Taufiq Rahman, B. Potter, 2010, Molecular Pharmacology.

Bicyclic analogues of D-myo-inositol 1,4,5-trisphosphate related to adenophostin A: synthesis and biological activity.

A. M. Riley, C. Taylor, B. Potter, 2001, Journal of Medicinal Chemistry.

Contribution of the adenine base to the activity of adenophostin A investigated using a base replacement strategy.

C. Taylor, B. Potter, V. Correa, 2000, Journal of Medicinal Chemistry.

Synthesis of potent agonists of the D-myo-inositol 1,4, 5-trisphosphate receptor based on clustered disaccharide polyphosphate analogues of adenophostin A.

G. A. van der Marel, A. Valentijn, C. Taylor, 2000, Journal of medicinal chemistry.

Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptors.

A. M. Riley, C. Taylor, B. Potter, 1997, Biochemistry.

A systematic study of C-glucoside trisphosphates as myo-inositol trisphosphate receptor ligands. Synthesis of beta-C-glucoside trisphosphates based on the conformational restriction strategy.

S. Shuto, A. Matsuda, B. Potter, 2006, Journal of Medicinal Chemistry.

An approach to a carbocyclic analogue of cyclic adenosine 5′-diphosphate ribose. The synthesis and bisphosphorylation of N1-[(1S, 3R)-3-(Hydroxymethyl)cyclopent-1-yl]inosine

B. Potter, S. Fortt, 1997 .

Activation of IP3 receptors by synthetic bisphosphate ligands† †Dedicated to Dr Melanie N. Trusselle (1973–2008).

A. M. Riley, B. Potter, S. G. Dedos, 2009, Chemical Communications.

Total Synthesis of Nucleobase‐Modified Adenophostin A Mimics.

S. Shuto, B. Potter, G. Horne, 2002 .

Adenophostin A and ribophostin, but not inositol 1,4,5-trisphosphate or manno-adenophostin, activate the Ca2+ release-activated Ca2+ current, I(CRAC), in weak intracellular Ca2+ buffer.

A. M. Riley, B. Potter, A. Parekh, 2002, The Biochemical journal.

Synthesis of Potent Agonists of the D-myo-Inositol 1,4,5-Trisphosphate Receptor Based on Clustered Disaccharide Polyphosphate Analogues of Adenophostin A.

A. Valentijn, J. H. Boom, B. Potter, 2000 .

Convergent Synthesis of Adenophostin A Analogues via a Base Replacement Strategy.

S. Shuto, B. Potter, D. J. Jenkins, 2000 .

A Disaccharide Polyphosphate Mimic of 1D-myo-Inositol 1,4,5- Trisphosphate.

B. Potter, D. J. Jenkins, R. D. Marwood, 1997 .

InsP, and Ins(I,3,4,5)P, act in synergy to stimulate influx of extracellular Ca2+ in Xenopus oocytes

M. Welsh, B. Potter, D. Pittet, 2002 .

Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor.

R. Davis, B. Potter, S. Ballereau, 1999, Journal of Medicinal Chemistry.

Interactions of Inositol 1,4,5-Trisphosphate (IP3) Receptors with Synthetic Poly(ethylene glycol)-linked Dimers of IP3 Suggest Close Spacing of the IP3-binding Sites*

A. M. Riley, S. Morris, B. Potter, 2002, The Journal of Biological Chemistry.

A Ca2+‐Mobilizing Carbohydrate‐Based Polyphosphate: Synthesis of 2‐ Hydroxyethyl α‐D‐Glucopyranoside 2′,3,4‐Trisphosphate.

B. Potter, D. J. Jenkins, 1996 .

InsP4 facilitates store-operated calcium influx by inhibition of InsP3 5-phosphatase

A. M. Riley, Meredith C. Hermosura, R. Penner, 2000, Nature.

A concise route to tiazofurin

B. Potter, J. Dowden, Christelle Moreau, 2002 .

Characterization of inositol 1,4,5-trisphosphate-sensitive (IsCaP) and-insensitive (IisCaP) nonmitochondrial Ca2+ pools in rat pancreatic acinar cells

B. Potter, F. Thévenod, T. Kemmer, 1989, The Journal of Membrane Biology.

Stereospecificity of nucleases towards phosphorothioate-substituted RNA: stereochemistry of transcription by T7 RNA polymerase.

I. Eperon, A. Griffiths, B. Potter, 1987, Nucleic acids research.

PENTAGON IP3 : SYNTHESIS OF A RING-CONTRACTED MIMIC OF A SECOND MESSENGER

A. M. Riley, B. Potter, D. J. Jenkins, 1995 .

Poly(ethylene glycol)-linked dimers of D-myo-inositol 1,4,5-trisphosphate

A. M. Riley, B. Potter, 2000 .

Inframolecular studies of the protonation of 1d-1,2,4/3,5-cyclopentanepentaol 1,3,4-trisphosphate, a ring-contracted analogue of 1d-myo-inositol 1,4,5-trisphosphate

G. Schlewer, B. Potter, V. Correa, 1999 .

Bicyclic Analogues of D‐myo‐Inositol 1,4,5‐Trisphosphate Related to Adenophostin A: Synthesis and Biological Activity.

A. M. Riley, B. Potter, V. Correa, 2001 .

First enzymatic synthesis of an N1-cyclised cADPR (cyclic-ADP ribose) analogue with a hypoxanthine partial structure: discovery of a membrane permeant cADPR agonist.

B. Potter, A. Guse, G. Wagner, 2003, Chemical communications.

An Approach to a Carbocyclic Analogue of Cyclic Adenosine 5′- Diphosphate Ribose. The Synthesis and Bisphosphorylation of N1-((1S,3R) -3-(Hydroxymethyl)cyclopent-1-yl)inosine.

B. Potter, S. Fortt, 2010 .

Ca2+ Entry Induced by Cyclic ADP-ribose in Intact T-Lymphocytes*

G. Mayr, B. Potter, A. Guse, 1997, The Journal of Biological Chemistry.

D-6-Deoxy-myo-inositol 1,3,4,5-tetrakisphosphate, a mimic of d-myo-inositol 1,3,4,5-tetrakisphosphate: biological activity and pH-dependent conformational properties.

R. Penner, A. Fleig, M. Hirata, 2004, Biochemical and biophysical research communications.

2-O-(2-Aminoethyl)-myo-inositol 1,4,5-trisphosphate as a novel ligand for conjugation: physicochemical properties and synthesis of a new Ins(1,4,5)P(3) affinity matrix.

A. M. Riley, B. Potter, B. Spiess, 2004, Biochemical and biophysical research communications.

Stimulation of Inositol 1,4,5-Trisphosphate (IP3) Receptor Subtypes by Analogues of IP3

A. M. Riley, B. Potter, Taufiq Rahman, 2013, PloS one.

Synthesis of D- and L-myo-inositol 2,4,5-trisphosphate and trisphosphorothioate: structural analogues of D-myo-inositol 1,4,5-trisphosphate.

B. Potter, S. J. Mills, Changsheng Liu, 2002, Carbohydrate research.

Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.

A. M. Riley, J. Westwick, B. Potter, 1996, Molecular pharmacology.

Cyclic Adenosine 5'-Diphosphate Ribose-Mediated Cellular Signalling: New Insights using Synthetic Ligands

B. Potter, 1999 .

First derivatives of myo-inositol 1,4,6-trisphosphate modified at positions 2 and 3: structural analogues of D-myo-inositol 1,4,5-trisphosphate.

B. Potter, S. J. Mills, G. Horne, 2004, Carbohydrate research.

Synthesis of the enantiomers of 6-deoxy-myo-inositol 1,3,4,5-tetrakisphosphate, structural analogues of myo-inositol 1,3,4,5-tetrakisphosphate.

B. Potter, G. Horne, 2001, Chemistry.

Adamantyl carboxamides and acetamides as potent human 11β-hydroxysteroid dehydrogenase type 1 inhibitors

Xiangdong Su, Mark P. Thomas, Mark P Thomas, 2012, Bioorganic & medicinal chemistry.

InsP3-induced Ca2+release in permeabilized invertebrate photoreceptors: a link between phototransduction and Ca2+stores

B. Potter, K. Ukhanov, S. J. Mills, 2001 .

A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate

A. M. Riley, M Broggini, M. Broggini, 2010, British Journal of Cancer.

Correction: Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response

A. M. Riley, Solomon H. Snyder, Ramnik J. Xavier, 2014, PLoS Pathogens.

Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase.

C. Supuran, A. Casini, A. Scozzafava, 2004, Bioorganic & medicinal chemistry letters.

Fast release of 45Ca2+ induced by inositol 1,4,5-trisphosphate and Ca2+ in the sarcoplasmic reticulum of rabbit skeletal muscle: evidence for two types of Ca2+ release channels.

C. Valdivia, B. Potter, R. Coronado, 1992, Biophysical journal.

Influences of separation and adjacent sequences on the use of alternative 5' splice sites.

I. Eperon, B. Potter, A. Else, 1991, Journal of molecular biology.

Distinct subcellular localisations of the putative inositol 1,3,4,5-tetrakisphosphate receptors GAP1IP4BP and GAP1m result from the GAP1IP4BP PH domain directing plasma membrane targeting

P. J. Cullen, P. Cullen, B. Potter, 1997, Current Biology.

The Role of 17β-Hydroxysteroid Dehydrogenases in Modulating the Activity of 2-Methoxyestradiol in Breast Cancer Cells

H. Tutill, B. Potter, J. Day, 2006 .

The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells.

H. Tutill, B. Potter, J. Day, 2006, Cancer research.

On the contribution of stereochemistry to human ITPK1 specificity: Ins(1,4,5,6)P4 is not a physiologic substrate

A. M. Riley, B. Potter, S. Adelt, 2006, FEBS letters.

The Role of 17 B -Hydroxysteroid Dehydrogenases in Modulating the Activity of 2-Methoxyestradiol in Breast Cancer Cells

H. Tutill, B. Potter, J. Day, 2005 .

Regioselective demethylation of aconitine

B. Potter, I. S. Blagbrough, S. Wonnacott, 1994 .

supplementary figures

A. M. Riley, S. Cowley, J. Schwabe, 2018 .

The inositol pyrophosphate 5-InsP7 drives sodium-potassium pump degradation by relieving an autoinhibitory domain of PI3K p85α

A. M. Riley, Alfred C. Chin, S. Snyder, 2020, Science Advances.

A metabolically stable analog of 1,4,5-inositol trisphosphate activates a novel K+ conductance in pyramidal cells of the rat hippocampal slice

B. Potter, Richard J. Miller, M. McCarren, 1989, Neuron.

Mobilization of calcium by inositol trisphosphates from permeabilized rat parotid acinar cells. Evidence for translocation of calcium from uptake to release sites within the inositol 1,4,5-trisphosphate- and thapsigargin-sensitive calcium pool.

F. Menniti, J. Putney, B. Potter, 1991, The Journal of biological chemistry.

Regioselective anthranoylation of demethylated aconitine : novel analogues of aconitine, inuline and methyllycaconitine

B. Potter, I. S. Blagbrough, S. Wonnacott, 1994 .

Modes of cell death induced by tetrahydroisoquinoline-based analogs in MDA-MB-231 breast and A549 lung cancer cell lines

B. Potter, A. Joubert, A. Theron, 2018, Drug design, development and therapy.

Inhibition of in vitro angiogenesis by 2‐methoxy‐ and 2‐ethyl‐estrogen sulfamates

B. Potter, A. Purohit, M. Reed, 2004, International journal of cancer.

Inositol 1,3,4,5-tetrakisphosphate-induced release of intracellular Ca2+ in SH-SY5Y neuroblastoma cells.

B. Potter, S. Nahorski, D. Gawler, 1990, The Biochemical journal.

The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX Expression.

Mark P Thomas, B. Potter, A. Purohit, 2015, Anticancer research.

Structure-activity studies of bicyclic and tricyclic analogues of methyllycaconitine.

B. Potter, A. Wolstenholme, I. S. Blagbrough, 1997, Biochemical Society transactions.

Quantal Ca2+ release mediated by very few IP3 receptors that rapidly inactivate allows graded responses to IP3

A. M. Riley, G. Dupont, B. Potter, 2021, Cell reports.

Synthesis of 1L-chiro-inositol 2,3,5-trisphosphorothioate, the first partial agonist at the platelet myo-inositol 1,4,5-trisphosphate receptor.

B V Potter, J. Westwick, B. Potter, 1994, Bioorganic & medicinal chemistry.

Molecular target sizes of inositol 1,4,5-trisphosphate receptors in liver and cerebellum.

C. Taylor, B. Potter, D. L. Nunn, 1990, The Biochemical journal.

Diversification in the inositol tris/tetrakisphosphate kinase (ITPK) family: crystal structure and enzymology of the outlier AtITPK4

A. M. Riley, C. Brearley, A. Hemmings, 2023, The Biochemical journal.

Nudicauline and elatine as potent norditerpenoid ligands at rat neuronal alpha-bungarotoxin binding sites: importance of the 2-(methylsuccinimido)benzoyl moiety for neuronal nicotinic acetylcholine receptor binding.

B. Potter, I. S. Blagbrough, S. Wonnacott, 1996, Journal of medicinal chemistry.

Inositol triphosphate produces different patterns of cytoplasmic Ca2+ spiking depending on its concentration

C. Petersen, B. Potter, O. Petersen, 1991, FEBS letters.

A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion

A. M. Riley, M. Falasca, T. Maffucci, 2016, Scientific Reports.

Analysis of the chirality of [16O,17O,18O] phosphate esters by 31P nuclear magnetic resonance spectroscopy

B. Potter, G. Lowe, R. L. Jarvest, 1981 .

Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate.

A. M. Riley, B V Potter, M. Saraste, 1999, Structure.

Synthesis of inorganic P1-[(S)-16O, 17O, 18O]pyrophosphate

B. Potter, G. Lowe, 1989 .

ANALYSIS OF THE CHIRALITY OF OXYGEN-16, -17, AND -18 PHOSPHATE ESTERS BY PHOSPHORUS-31 NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY

B. Potter, G. Lowe, R. L. Jarvest, 1982 .

A general chemical method for the stereochemical analysis of nucleoside-5′ [ 16O, 18 O] phosphorothioates

B. Potter, J. H. Cummins, 1987 .

Investigation of the inframolecular acid-base properties of D-myo-inositol 1,3,4,5-tetrakisphosphate and DL-myo-inositol 1,2,4,5-tetrakisphosphate

A. M. Riley, G. Schlewer, B. Potter, 1997 .

Inositol hexakisphosphate increases the size of platelet aggregates

A. M. Riley, F. Gräter, G. Mayr, 2019, Biochemical pharmacology.

Adamantyl Ethanone Pyridyl Derivatives: Potent and Selective Inhibitors of Human 11β-Hydroxysteroid Dehydrogenase Type 1

Mark P Thomas, B. Potter, M. Culler, 2011, ChemMedChem.

Itraconazole inhibits endothelial cell migration by disrupting inositol pyrophosphate-dependent focal adhesion dynamics and cytoskeletal remodeling

A. M. Riley, Alfred C. Chin, D. Fiedler, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Synthesis of an alpha-phosphono-alpha , alpha-difluoroacetamide analogue of the diphosphoinositol pentakisphosphate 5-InsP7.

A. M. Riley, Huanchen Wang, B. Potter, 2019 .

Synthetic Inositol Phosphate Analogs Reveal that PPIP5K2 Has a Surface-Mounted Substrate Capture Site that Is a Target for Drug Discovery

A. M. Riley, Huanchen Wang, H. Y. Godage, 2014, Chemistry & biology.

Structural and Biochemical Evaluation of the Interaction of the Phosphatidylinositol 3-Kinase p85α Src Homology 2 Domains with Phosphoinositides and Inositol Polyphosphates*

A. M. Riley, G. Siegal, G. Panayotou, 1999, The Journal of Biological Chemistry.

Novel inositol phospholipid headgroup surrogate crystallized in the pleckstrin homology domain of protein kinase Balpha.

D. V. van Aalten, D. Komander, B. Potter, 2007, ACS chemical biology.

3,17-disubstituted 2-alkylestra-1,3,5(10)-trien-3-ol derivatives: synthesis, in vitro and in vivo anticancer activity.

B. Potter, A. Purohit, M. Reed, 2007, Journal of medicinal chemistry.

Biphenyl 2,3′,4,5′,6‐pentakisphosphate, a novel inositol polyphosphate surrogate, modulates Ca2+ responses in rat hepatocytes

G. Dupont, L. Missiaen, J. Parys, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Inhibition of inositol 1,4,5-trisphosphate metabolism in permeabilised SH-SY5Y human neuroblastoma cells by a phosphorothioate-containing analogue of inositol 1,4,5-trisphosphate.

S R Nahorski, R J Wojcikiewicz, A M Cooke, 1990, European journal of biochemistry.

Synthesis of myo-inositol 1,4-bisphosphate-5-phosphorothioate

N. J. Noble, B. Potter, R. Gigg, 1989 .

myo-Inositol 1,4-bisphosphate-5-phosphorothioate: chemical synthesis and biochemical properties

N. J. Noble, B. Potter, S. Nahorski, 1988 .

Determination of neo- and d-chiro-Inositol Hexakisphosphate in Soils by Solution 31P NMR Spectroscopy

A. M. Riley, Benjamin L Turner, H. Y. Godage, 2012, Environmental science & technology.

Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamate.

B. Potter, A. Purohit, M. Reed, 2010, Journal of medicinal chemistry.

Inositol 1,3,4,5-tetrakisphosphate is essential for sustained activation of the Ca2+-dependent K+ current in single internally perfused mouse lacrimal acinar cells

O. Petersen, B. Potter, R. Irvine, 1989, The Journal of Membrane Biology.

Rapid Synthesis of the Enantiomers of myo-Inositol-1,3,4,5-tetrakisphosphate by Direct Chiral Desymmetrization of myo-Inositol Orthoformate†

A. M. Riley, B. Potter, M. Mahon, 1997 .

The behaviour of inositol 1,3,4,5,6-pentakisphosphate in the presence of the major biological metal cations

A. M. Riley, H. Y. Godage, B. Potter, 2009, JBIC Journal of Biological Inorganic Chemistry.

The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer

B. Potter, A. Purohit, M. Reed, 2008, British Journal of Cancer.

2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumour agents.

B. Potter, A. Purohit, M. Reed, 2004, Bioorganic & medicinal chemistry letters.

An Antagonist of cADP-ribose Inhibits Arrhythmogenic Oscillations of Intracellular Ca2+ In Heart Cells*

A. Galione, B. Potter, Yi Cui, 1999, The Journal of Biological Chemistry.

A specific cyclic ADP-ribose antagonist inhibits cardiac excitation–contraction coupling

A. Galione, B. Potter, G. A. Ashamu, 1996, Current Biology.

CHEMICAL SYNTHESIS OF THE NOVEL CA2+ MESSENGER NAADP

A. Galione, B. Potter, J. Dowden, 2005, Nucleosides, nucleotides & nucleic acids.

Synthesis and Structure–Activity Relationship Studies of Derivatives of the Dual Aromatase–Sulfatase Inhibitor 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate

B. Potter, Mark P Thomas, B. Potter, 2013, ChemMedChem.

First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors.

M. D. Lloyd, K. Acharya, B. Potter, 2005, Biochemistry.

The stereochemical course of yeast hexokinase-catalysed phosphoryl transfer by using adenosine 5'[gamma(S)-16O,17O,18O]triphosphate as substrate.

B. Potter, G. Lowe, 1981, The Biochemical journal.

Stereochemistry of phosphoryl transfer.

P. Cullis, B. Sproat, B. Potter, 1981, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

Facilitation of the responses to injections of inositol 1,4,5-trisphosphate analogs in Limulus ventral photoreceptors.

P. Hillman, R. Payne, B. Potter, 1994, Biophysical journal.

D‐[35S(U)]Inositol 1,4,5‐trisphosphorothioate, a novel radioligand for the inositol 1,4,5‐trisphosphate receptor Complex binding to rat cerebellar membranes

R. Challiss, B. Potter, S. Nahorski, 1991, FEBS letters.

Myo‐inositol 1,3,4,5‐tetrakisphosphate can independently mobilise intracellular calcium, via the inositol 1,4,5‐trisphosphate receptor: studies with myo‐inositol 1,4,5‐trisphosphate‐3‐phosphorothioate and myo‐inositol hexakisphosphate

E. Whitham, B. Potter, S. Nahorski, 1993, FEBS letters.

A stereochemical investigation of phosphoryl transfer catalysed by phosphoglucomutase by the use of alpha-D-glucose 1-[(S)-16O,17O,18O]phosphate.

B. Potter, G. Lowe, 1981, The Biochemical journal.

The design of novel 17β-hydroxysteroid dehydrogenase type 3 inhibitors

Michael J. Reed, Atul Purohit, H. Tutill, 2009, Molecular and Cellular Endocrinology.

Chiral desymmetrisation of myo-inositol 1,3,5-orthobenzoate gives rapid access to precursors for second messenger analogues

A. M. Riley, H. Y. Godage, B. Potter, 2006 .

Crystal structure of human carbonic anhydrase II at 1.95 A resolution in complex with 667-coumate, a novel anti-cancer agent.

M. D. Lloyd, R. Natesh, K. Acharya, 2005, The Biochemical journal.

Synthesis of [17O]‐ and [18O]‐labelled hypophosphate

B. Potter, 1989 .

The stereochemical course of phosphoryl transfer catalysed by Bacillus stearothermophilus and rabbit skeletal-muscle phosphofructokinase with a chiral [16O,17O,18O]phosphate ester.

B. Potter, G. Lowe, R. L. Jarvest, 1981, The Biochemical journal.

Unambiguous total synthesis of the enantiomers of myo-inositol 1,3,4-trisphosphate: 1L-myo-inositol 1,3,4-trisphosphate mobilizes intracellular Ca2+ in Limulus photoreceptors.

A. M. Riley, R. Payne, B. Potter, 1994, Journal of medicinal chemistry.

Phosphorylation of inositol 1,4,5-trisphosphate analogues by 3-kinase and dephosphorylation of inositol 1,3,4,5-tetrakisphosphate analogues by 5-phosphatase.

P. V. van Haastert, B. Potter, C. Erneux, 1994, European journal of biochemistry.

Inhibition of human and rat 11beta-hydroxysteroid dehydrogenase type 1 by 18beta-glycyrrhetinic acid derivatives.

B. Potter, A. Purohit, M. Reed, 2007, The Journal of steroid biochemistry and molecular biology.

A stereospecifically 18O-labelled deoxydinucleoside phosphate block for incorporation into an oligonucleotide.

B. Potter, F. Eckstein, B. Uznański, 1983, Nucleic acids research.

Oxygen Chiral Phosphate in Ribo- and 2′-Deoxyribodinucleoside Monophosphates by Oxidation of Phosphite Intermediates

B. Potter, F. Seela, J. Ott, 1985 .

myo-Inositol 1,4,5-trisphosphorothioate: a novel analogue of a biological second messenger

B. Potter, R. Gigg, A. Cooke, 1987 .

Crystal Structures of Type-II Inositol Polyphosphate 5-Phosphatase INPP5B with Synthetic Inositol Polyphosphate Surrogates Reveal New Mechanistic Insights for the Inositol 5-Phosphatase Family

P. Nordlund, B. Potter, G. Cozier, 2016, Biochemistry.

Is decavanadate a specific inositol 1,4,5-trisphosphate receptor antagonist?

R. Wojcikiewicz, R. Challiss, B. Potter, 1991, The Biochemical journal.

Synthesis of L-chiro-inositol 1,4,6-trisphosphorothioate, a potent and selective inhibitor of myo-inositol 1,4,5-trisphosphate 5-phosphatase

B. Potter, Changsheng Liu, Stefan R. Nahorski, 1992 .

Total synthesis from L-quebrachitol of the D-myo-inositol 1,4,5-trisphosphate analogue, L-chiro-inositol 2,3,5-trisphosphate, a potent inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase inhibitor

B. Potter, Changsheng Liu, Stefan R. Nahorski, 1991 .

Bovine testis and human erythrocytes contain different subtypes of membrane-associated Ins(1,4,5)P3/Ins(1,3,4,5)P4 5-phosphomonoesterases.

B. Potter, R. Michell, A. Craxton, 1994, The Biochemical journal.

Benzene Polyphosphates as Tools for Cell Signalling: Inhibition of Inositol 1,4,5‐Trisphosphate 5‐Phosphatase and Interaction with the PH Domain of Protein Kinase Bα

B. Potter, F. Vandeput, C. Erneux, 2008, Chembiochem : a European journal of chemical biology.

Rapid and practical synthesis of D-myo-inositol 1,4,5-trisphosphate

A. M. Riley, B. Potter, S. Garrett, 1998 .

Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents.

B. Potter, A. Purohit, S. Newman, 2011, Journal of medicinal chemistry.

Biphenyl 2,3 (cid:1) ,4,5 (cid:1) ,6-pentakisphosphate, a novel inositol polyphosphate surrogate, modulates Ca 2 (cid:1) responses in rat hepatocytes

G. Dupont, L. Missiaen, J. Parys, 2007 .

Synthesis of DL-Myo-inositol 1,4,5-triphosphate

B. Potter, R. Gigg, A. Cooke, 1987 .

Inositol 1,4,5-trisphosphate receptor subtypes differentially recognize regioisomers of D-myo-inositol 1,4,5-trisphosphate.

A. M. Riley, H. Takeuchi, M. Hirata, 1997, The Biochemical journal.

Interactions between inositol tris- and tetrakis-phosphates. Effects on intracellular Ca2+ mobilization in SH-SY5Y cells.

B. Potter, S. Nahorski, R. Gigg, 1991, The Biochemical journal.

Modulation of the substrate specificity of the kinase PDK1 by distinct conformations of the full-length protein

A. M. Riley, C. Camacho, D. Svergun, 2023, Science Signaling.

STX2171, a 17b-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model

H. Tutill, B. Potter, J. Day, 2013 .

Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.

B. Potter, B. Potter, A. Purohit, 2000, Chemistry & biology.

Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity

B. Potter, A. Purohit, M. Reed, 2003, The Journal of Steroid Biochemistry and Molecular Biology.

Characterization of inositol 1,4,5-trisphosphate- and inositol 1,3,4,5-tetrakisphosphate-binding sites in rat cerebellum.

R. Challiss, B. Potter, B. Mulloy, 1991, Biochemical Journal.

Novel and potent 17β-hydroxy steroid dehydrogenase type 1 inhibitors

H. Tutill, B. Potter, A. Purohit, 2005 .

Tetrahydroisoquinoline Sulfamates as Potent Microtubule Disruptors: Synthesis, Antiproliferative and Antitubulin Activity of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal Structure

M. Steinmetz, A. Prota, B. Potter, 2019, ACS omega.

A new micronized formulation of 2-methoxyestradiol-bis-sulfamate (STX140) is therapeutically potent against breast cancer.

B. Potter, A. Purohit, M. Reed, 2008, Anticancer Research.

The stereochemistry of 2-substituted-2-oxo-4,5-diphenyl-1,3,2-dioxaphospholans and the related chiral [16O,17O,18O]phosphate monoesters

P. Cullis, B. Potter, G. Lowe, 1981 .

Discovery of novel inhibitors of human 11β-hydroxysteroid dehydrogenase type 1

B. Potter, M. Culler, N. Vicker, 2009, Molecular and Cellular Endocrinology.

and Ca2+inthesarcoplasmic reticulum ofrabbit skeletal muscle: evidence fortwotypesofCa2+release channels

B. Potter, 1992 .

Designer small molecules to target calcium signalling.

A. M. Riley, B. Potter, S. J. Mills, 2015, Biochemical Society transactions.

Modes of cell death induced by tetrahydroisoquinoline-based analogs in MDa-MB-231 breast and a549 lung cancer cell lines

B. Potter, A. Theron, W. Dohle, 2018 .

A definitive synthesis of D-myo-inositol 1,4,5,6-tetrakisphosphate and its enantiomer D-myo-inositol 3,4,5,6-tetrakisphosphate from a novel butane-2,3-diacetal-protected inositol.

A. M. Riley, B. Potter, M. Mahon, 2003, Chemistry.